Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-26-041807
Filing Date
2026-09-08
Accepted
2026-09-08 17:29:33
Documents
11
Period of Report
2026-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A form8-ka.htm   iXBRL 8-K/A 69044
  Complete submission text file 0001493152-26-041807.txt   241357

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vvos-20260902.xsd EX-101.SCH 3005
3 XBRL LABEL FILE vvos-20260902_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE vvos-20260902_pre.xml EX-101.PRE 22352
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4046
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39796 | Film No.: 261365993
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)